PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 1,380.00
+15.00 (1.10%)
Nov 13, 2026, 1:30 PM CST
PharmaEssentia Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 24,618 | 15,635 | 9,735 | 5,106 | 2,882 | 656.51 |
Revenue Growth | 78.20% | 60.61% | 90.67% | 77.15% | 339.00% | 17.81% |
Gross Profit Gross Profit Growth | 22,812 | 13,950 | 8,558 | 4,495 | 2,070 | 277.65 |
Operating Income Operating Income Growth | 9,930 | 4,928 | 1,736 | -1,913 | -2,028 | -2,822 |
Net Income Net Income Growth | 9,079 | 5,045 | 2,966 | -623.84 | -1,375 | -2,811 |
Earnings Per Share EPS Growth | 21.98 | 12.25 | 7.21 | -1.57 | -3.93 | -8.78 |
EPS Growth | 88.27% | 69.88% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue from Sale of Medicine Products Revenue from Sale of Medicine Products Growth | 20,616 | 15,551 | 9,674 | 4,941 | 2,879 | 633.15 |
Revenue from Royalty Income Revenue from Royalty Income Growth | 110.36 | 52.91 | - | - | - | - |
Revenue Arising from Rendering of Services Revenue Arising from Rendering of Services Growth | 25.26 | 31.26 | 28.87 | 11.39 | 2.64 | 23.36 |
Other Sales Other Sales Growth | - | - | 31.96 | 153.58 | - | - |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 26,764 | 22,693 | 21,051 | 19,666 | 10,304 | 3,454 |
Total Debt Total Debt Growth | 1,105 | 856.03 | 965.43 | 1,200 | 1,569 | 536.24 |
Net Cash (Debt) Net Cash Growth | 25,659 | 21,837 | 20,086 | 18,466 | 8,735 | 2,917 |
Net Cash Growth | 24.02% | 8.72% | 8.77% | 111.40% | 199.41% | 13.71% |
Net Cash Per Share Net Cash Per Share Growth | 62.12 | 53.04 | 48.85 | 46.52 | 24.97 | 9.11 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 10,315 | 5,278 | 2,525 | -709.51 | -1,505 | -2,462 |
Capital Expenditures CapEx Growth | -3,450 | -1,911 | -862 | -1,286 | -312.03 | -70.33 |
Free Cash Flow Free Cash Flow Growth | 6,865 | 3,366 | 1,663 | -1,996 | -1,818 | -2,532 |
Free Cash Flow Growth | 126.92% | 102.47% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 92.67% | 89.23% | 87.91% | 88.04% | 71.82% | 42.29% |
Operating Margin | 40.34% | 31.52% | 17.83% | -37.48% | -70.37% | -429.91% |
Pretax Margin | 43.87% | 31.87% | 30.76% | -19.33% | -63.91% | -428.17% |
Profit Margin | 36.88% | 32.27% | 30.46% | -12.22% | -47.70% | -428.17% |
FCF Margin | 27.89% | 21.53% | 17.08% | -39.09% | -63.06% | -385.74% |
Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 1.352 | 1.352 | 0.894 |
Dividend Per Share Growth | 0% | 51.32% | - |
Dividend Yield | 0.10% | 0.32% | 0.18% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 62.78 | 34.45 | 69.04 | - | - | - |
Forward PE | 37.24 | 25.16 | 41.36 | 31.89 | 69.03 | - |
P/FCF Ratio | 83.31 | 51.64 | 123.13 | - | - | - |
PS Ratio | 23.23 | 11.12 | 21.03 | 22.44 | 49.91 | 118.91 |